Abhishek V. Alluri

Internal Medicine

304 Turner McCall Blvd SW
Rome, GA 30165

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Low-dose-rate prostate brachytherapy: 4-8 week postimplant prostate-specific antigen a novel predictor of biochemical failure-free survival.

Low-dose-rate prostate brachytherapy: 4-8 week postimplant prostate-specific antigen a novel predictor of biochemical failure-free survival.

Journal: Brachytherapy

Published: May 05, 2017

Showing 1-1 of 1

Last Updated: 09/26/2026